Dr. Daniel Rothstein, MD

Dr. Rothstein practices at University Hospital in Newark, New Jersey, part of State of New Jersey.

Dr. Rothstein's NPI, 1063707065, was assigned on June 17, 2011. Dr. Rothstein holds New Jersey license 25MA09919000.

Dr. Rothstein's primary practice is University Hospital, at 150 Bergen St, Newark, NJ 07103 in Essex County. The practice phone is (973) 972-4300.

Dr. Rothstein's primary practice is University Hospital in Newark, New Jersey, part of State of New Jersey. Dr. Rothstein is also affiliated with Morristown Medical Center. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Rothstein to 3 more hospitals, 6 medical groups, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rothstein practices, 7 sites in all. Vendor and product names are available with a free account.

Pain medicine is Dr. Rothstein's primary specialty in the NPI Registry, under taxonomy code 207LP2900X. Dr. Rothstein is licensed in New Jersey.

CMS data shows 271 Medicare services from Dr. Rothstein across 14 procedure codes in 2024, for 365 Medicare patients. Medicare paid $27,485 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 365 Medicare patients who saw Dr. Rothstein in 2024. The largest group is 65 to 74, with 148 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rothstein's median patient age at 68, with 49% women.

In 2022, Dr. Rothstein wrote 296 Medicare Part D claims. They cover 7 drugs, with $7,241 in total drug cost. In 2021, CMS named 593 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Rothstein for performance year 2024, reported as part of a group. Dr. Rothstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 133 general payments to Dr. Rothstein from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 56% of the total. Abbott Laboratories paid the most, $1,747.